These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38606731)
1. Prognostic factors and predictive models for patients with lung large cell neuroendocrine carcinoma: Based on SEER database. Li W; Huang Q; He X; He Q; Lai Q; Yuan Q; Deng Z Clin Respir J; 2024 Apr; 18(4):e13752. PubMed ID: 38606731 [TBL] [Abstract][Full Text] [Related]
2. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study. Song Z; Zou L Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892 [TBL] [Abstract][Full Text] [Related]
3. [Development and Validation of A Prognostic Nomogram to Guide Decision-making in Lung Large Cell Neuroendocrine Carcinoma]. Chen S; Li S; Wang Z; Zhang W; Zhou L; Jiao W Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):487-496. PubMed ID: 37653012 [TBL] [Abstract][Full Text] [Related]
4. Establishment and Validation of Prognostic Nomograms for Patients with Metastatic Pulmonary Large Cell Neuroendocrine Carcinoma. Chen X; Lai X; Huang Y; Deng C Cancer Control; 2024; 31():10732748241274195. PubMed ID: 39134429 [TBL] [Abstract][Full Text] [Related]
5. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma. He Y; Liu H; Wang S; Chen Y PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723 [TBL] [Abstract][Full Text] [Related]
6. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer. Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179 [TBL] [Abstract][Full Text] [Related]
7. Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study. Mu X; Pu D; Zhu Y; Zhou Y; Wu Q; Liu Q; Yin L; Li Y J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373819 [TBL] [Abstract][Full Text] [Related]
8. Early death incidence and prediction in stage IV large cell neuroendocrine carcinoma of the lung. Xing H; Wu C; Zhang D; Zhang X Medicine (Baltimore); 2024 Sep; 103(37):e39294. PubMed ID: 39287289 [TBL] [Abstract][Full Text] [Related]
9. Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis. Chen X; Huang Y; Chen F; She H; Chen X Cancer Med; 2023 Feb; 12(4):4087-4099. PubMed ID: 36125491 [TBL] [Abstract][Full Text] [Related]
10. Construction of web Zhan G; Cao P; Peng H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884 [TBL] [Abstract][Full Text] [Related]
11. Personalized prognostic prediction tool for high-grade neuroendocrine cervical cancer: a SEER database analysis and single-center validation. Chen X; Shi W; Wang C; Zhu H J Cancer Res Clin Oncol; 2023 Dec; 149(19):17395-17404. PubMed ID: 37853082 [TBL] [Abstract][Full Text] [Related]
12. Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis. Shi H; Li X; Chen Z; Jiang W; Dong S; He R; Zhou W J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983591 [TBL] [Abstract][Full Text] [Related]
13. A Clinical Nomogram for Predicting Cancer-Specific Survival in Pulmonary Large-Cell Neuroendocrine Carcinoma Patients: A Population-Based Study. Ma H; Xu Z; Zhou R; Liu Y; Zhu Y; Chang X; Chen Y; Zhang H Int J Gen Med; 2021; 14():7299-7310. PubMed ID: 34737624 [TBL] [Abstract][Full Text] [Related]
14. Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study. Jiang T; Sun H; Li N; Jiang T J Cancer Res Clin Oncol; 2023 Nov; 149(15):13511-13521. PubMed ID: 37498395 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer. Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444 [TBL] [Abstract][Full Text] [Related]
16. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis. Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148 [TBL] [Abstract][Full Text] [Related]
17. Nomogram predicts risk and prognostic factors for lung metastasis of anaplastic thyroid carcinoma: a retrospective study in the Surveillance Epidemiology and End Results (SEER) database. Bi J; Zhang H Transl Cancer Res; 2023 Dec; 12(12):3547-3564. PubMed ID: 38192974 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database. Huang G; Liao J; Cai S; Chen Z; Qin X; Ba L; Rao J; Zhong W; Lin Y; Liang Y; Wei L; Li J; Deng K; Li X; Guo Z; Wang L; Zhuo Y Front Oncol; 2022; 12():949058. PubMed ID: 36237316 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma. Xi J; Zhao M; Zheng Y; Liang J; Hu Z; Huang Y; Yang Y; Zhan C; Jiang W; Lu T; Guo W; Wang Q Transl Cancer Res; 2020 Aug; 9(8):4943-4957. PubMed ID: 35117856 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort. Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]